A detailed history of Kestra Private Wealth Services, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Kestra Private Wealth Services, LLC holds 6,292 shares of EW stock, worth $412,000. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,292
Previous 4,674 34.62%
Holding current value
$412,000
Previous $446,000 30.27%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$84.3 - $94.31 $136,397 - $152,593
1,618 Added 34.62%
6,292 $581,000
Q1 2024

May 02, 2024

SELL
$72.54 - $95.56 $8,849 - $11,658
-122 Reduced 2.54%
4,674 $446,000
Q4 2023

Feb 05, 2024

BUY
$61.71 - $77.76 $24,437 - $30,792
396 Added 9.0%
4,796 $365,000
Q3 2023

Nov 07, 2023

BUY
$69.28 - $93.38 $4,988 - $6,723
72 Added 1.66%
4,400 $304,000
Q2 2023

Aug 08, 2023

BUY
$81.41 - $94.33 $22,306 - $25,846
274 Added 6.76%
4,328 $408,000
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $65,720 - $74,791
-885 Reduced 17.92%
4,054 $335,000
Q4 2022

Jan 31, 2023

SELL
$68.3 - $87.44 $316,502 - $405,196
-4,634 Reduced 48.41%
4,939 $368,000
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $11,284 - $14,698
-137 Reduced 1.41%
9,573 $791,000
Q2 2022

Aug 12, 2022

BUY
$86.5 - $128.27 $30,275 - $44,894
350 Added 3.74%
9,710 $923,000
Q1 2022

May 26, 2022

SELL
$101.96 - $128.34 $406,718 - $511,948
-3,989 Reduced 29.88%
9,360 $1.1 Million
Q4 2021

Jan 21, 2022

BUY
$106.37 - $130.68 $447,285 - $549,509
4,205 Added 45.99%
13,349 $1.73 Million
Q3 2021

Oct 21, 2021

BUY
$102.91 - $122.75 $51,352 - $61,252
499 Added 5.77%
9,144 $1.04 Million
Q2 2021

Jul 30, 2021

BUY
$83.84 - $104.76 $10,899 - $13,618
130 Added 1.53%
8,645 $895,000
Q1 2021

May 11, 2021

BUY
$78.68 - $90.67 $669,960 - $772,055
8,515 New
8,515 $712,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Kestra Private Wealth Services, LLC Portfolio

Follow Kestra Private Wealth Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.